Meeder Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-1,774
| Closed | -$47.5K | – | 951 |
|
2024
Q2 | $47.5K | Buy |
+1,774
| New | +$47.5K | ﹤0.01% | 346 |
|
2022
Q4 | – | Sell |
-17
| Closed | -$1K | – | 1862 |
|
2022
Q3 | $1K | Buy |
17
+1
| +6% | +$59 | ﹤0.01% | 2021 |
|
2022
Q2 | $0 | Sell |
16
-229
| -93% | – | ﹤0.01% | 2425 |
|
2022
Q1 | $8K | Buy |
+245
| New | +$8K | ﹤0.01% | 1646 |
|
2021
Q4 | – | Sell |
-292
| Closed | -$8K | – | 2203 |
|
2021
Q3 | $8K | Buy |
292
+33
| +13% | +$904 | ﹤0.01% | 1768 |
|
2021
Q2 | $8K | Sell |
259
-1,660
| -87% | -$51.3K | ﹤0.01% | 1795 |
|
2021
Q1 | $50K | Buy |
+1,919
| New | +$50K | ﹤0.01% | 1106 |
|
2020
Q4 | – | Sell |
-4,946
| Closed | -$102K | – | 2206 |
|
2020
Q3 | $102K | Buy |
+4,946
| New | +$102K | 0.01% | 777 |
|
2019
Q2 | – | Sell |
-819
| Closed | -$28K | – | 2136 |
|
2019
Q1 | $28K | Sell |
819
-61
| -7% | -$2.09K | ﹤0.01% | 990 |
|
2018
Q4 | $30K | Buy |
880
+736
| +511% | +$25.1K | ﹤0.01% | 943 |
|
2018
Q3 | $7K | Sell |
144
-96
| -40% | -$4.67K | ﹤0.01% | 1257 |
|
2018
Q2 | $14.4K | Sell |
240
-952
| -80% | -$57K | ﹤0.01% | 1050 |
|
2018
Q1 | $55K | Sell |
1,192
-1,329
| -53% | -$61.3K | 0.01% | 651 |
|
2017
Q4 | $100K | Buy |
2,521
+249
| +11% | +$9.88K | 0.01% | 565 |
|
2017
Q3 | $91K | Sell |
2,272
-110
| -5% | -$4.41K | 0.01% | 581 |
|
2017
Q2 | $103K | Buy |
2,382
+2,315
| +3,455% | +$100K | 0.01% | 555 |
|
2017
Q1 | $2K | Buy |
+67
| New | +$2K | ﹤0.01% | 1405 |
|
2016
Q3 | – | Sell |
-2,307
| Closed | -$47K | – | 935 |
|
2016
Q2 | $47K | Sell |
2,307
-23,509
| -91% | -$479K | ﹤0.01% | 732 |
|
2016
Q1 | $394K | Hold |
25,816
| – | – | 0.04% | 458 |
|
2015
Q4 | $347K | Sell |
25,816
-23,351
| -47% | -$314K | 0.03% | 438 |
|
2015
Q3 | $690K | Buy |
+49,167
| New | +$690K | 0.07% | 273 |
|